InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（18 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
18
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Rawcliffe Adrian, 首席执行官. Director active across 3 companies, notably Adaptimmune Therapeutics PLC. Aggregated, 21 filings have been recorded. Split: 0 buy · 18 sells. Total volume traded: €371k. History available since 28 June 2021. The latest transaction was filed on 12 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Rawcliffe Adrian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
12,700 股@ US$5.29100.0% 占其流量Common StockSEC:0001193125-26-349962:0
42,000 股@ US$5.9769.5% 占其流量Ordinary SharesSEC:0001193125-25-314742:0
16,115 股@ US$6.79100.0% 占其流量Ordinary SharesSEC:0001193125-25-283619:0
12,700 股0Ordinary SharesSEC:0000950170-25-108286:0
30,601 股@ US$0.58085.1% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-25-004605:0
12,539 股@ US$0.58792.1% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-25-003775:0
16,115 股0Ordinary SharesSEC:0000950170-24-097290:0
9,304 股@ US$0.792.0% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-24-004564:0
11,945 股@ US$0.83672.7% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-24-003742:0
2,403 股@ US$0.780.5% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-23-097853:0
2,333 股@ US$0.920.6% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-23-075407:0
10,057 股@ US$1.8585.1% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-23-004379:0
13,042 股@ US$1.74686.3% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-23-003534:0
5,073 股@ US$1.6942.4% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-23-001088:0
2,536 股@ US$1.96891.5% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-22-097135:0
2,562 股@ US$1.631.2% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-22-074926:0
11,096 股@ US$3.191814.2% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-22-005053:0
14,362 股@ US$3.556720.7% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-22-004149:0
5,532 股@ US$4.06429.1% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-22-001668:0
2,782 股@ US$5.1955.6% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-21-112179:0
2,794 股@ US$4.374.7% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-21-086385:0
21 条申报中的 21 条
About Rawcliffe Adrian
Chief Executive Officer at Adaptimmune Therapeutics PLC and Director at Wave Life Sciences Ltd., Rawcliffe Adrian has 20 filings in total. Across the 20 sampled filings between 2021-06-28 and 2025-12-10, the recorded transactions are all disposals, with total sales of EUR 312383 and no purchases.
